HEADER IMMUNE SYSTEM 11-NOV-17 6BLR TITLE CRYSTAL STRUCTURE OF IAG7 IN COMPLEX WITH INSULIN MIMOTOPE P8E9E6SS COMPND MOL_ID: 1; COMPND 2 MOLECULE: IAG7 ALPHA CHAIN; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES; COMPND 5 MUTATION: YES; COMPND 6 MOL_ID: 2; COMPND 7 MOLECULE: H2-AB1 PROTEIN; COMPND 8 CHAIN: B; COMPND 9 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 3 ORGANISM_COMMON: MOUSE; SOURCE 4 ORGANISM_TAXID: 10090; SOURCE 5 EXPRESSION_SYSTEM: TRICHOPLUSIA NI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 7111; SOURCE 7 EXPRESSION_SYSTEM_CELL_LINE: HI5; SOURCE 8 MOL_ID: 2; SOURCE 9 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 10 ORGANISM_COMMON: MOUSE; SOURCE 11 ORGANISM_TAXID: 10090; SOURCE 12 GENE: H2-AB1; SOURCE 13 EXPRESSION_SYSTEM: TRICHOPLUSIA NI; SOURCE 14 EXPRESSION_SYSTEM_TAXID: 7111; SOURCE 15 EXPRESSION_SYSTEM_CELL_LINE: HI5 KEYWDS INSULIN, TYPE I DIABETES, T CELL, AUTOIMMUNE DISEASE, IMMUNE SYSTEM EXPDTA X-RAY DIFFRACTION AUTHOR Y.WANG,S.DAI REVDAT 6 11-DEC-19 6BLR 1 SEQADV REVDAT 5 14-MAR-18 6BLR 1 SEQADV REVDAT 4 17-JAN-18 6BLR 1 REMARK REVDAT 3 10-JAN-18 6BLR 1 JRNL REVDAT 2 03-JAN-18 6BLR 1 JRNL REVDAT 1 20-DEC-17 6BLR 0 JRNL AUTH Y.WANG,T.SOSINOWSKI,A.NOVIKOV,F.CRAWFORD,D.B.NEAU,J.YANG, JRNL AUTH 2 W.W.KWOK,P.MARRACK,J.W.KAPPLER,S.DAI JRNL TITL C-TERMINAL MODIFICATION OF THE INSULIN B:11-23 PEPTIDE JRNL TITL 2 CREATES SUPERAGONISTS IN MOUSE AND HUMAN TYPE 1 DIABETES. JRNL REF PROC. NATL. ACAD. SCI. V. 115 162 2018 JRNL REF 2 U.S.A. JRNL REFN ESSN 1091-6490 JRNL PMID 29255035 JRNL DOI 10.1073/PNAS.1716527115 REMARK 2 REMARK 2 RESOLUTION. 1.96 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (1.12_2829: ???) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.96 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 40.59 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.360 REMARK 3 COMPLETENESS FOR RANGE (%) : 72.1 REMARK 3 NUMBER OF REFLECTIONS : 24967 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.173 REMARK 3 R VALUE (WORKING SET) : 0.171 REMARK 3 FREE R VALUE : 0.228 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.920 REMARK 3 FREE R VALUE TEST SET COUNT : 1229 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 40.6007 - 4.0744 0.67 2557 126 0.1531 0.2046 REMARK 3 2 4.0744 - 3.2344 0.71 2596 148 0.1571 0.1887 REMARK 3 3 3.2344 - 2.8257 0.74 2716 141 0.1808 0.2451 REMARK 3 4 2.8257 - 2.5674 0.75 2709 156 0.1860 0.2531 REMARK 3 5 2.5674 - 2.3834 0.76 2748 138 0.1848 0.2680 REMARK 3 6 2.3834 - 2.2429 0.77 2786 146 0.1819 0.2445 REMARK 3 7 2.2429 - 2.1306 0.77 2798 142 0.1767 0.2550 REMARK 3 8 2.1306 - 2.0378 0.75 2714 128 0.1839 0.2490 REMARK 3 9 2.0378 - 1.9594 0.58 2114 104 0.1860 0.2724 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.200 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 22.150 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.007 3188 REMARK 3 ANGLE : 0.974 4340 REMARK 3 CHIRALITY : 0.062 469 REMARK 3 PLANARITY : 0.005 563 REMARK 3 DIHEDRAL : 7.345 2236 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6BLR COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 13-NOV-17. REMARK 100 THE DEPOSITION ID IS D_1000231077. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 24-JAN-14 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 24-ID-C REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9795 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 24967 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.960 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 74.6 REMARK 200 DATA REDUNDANCY : 4.500 REMARK 200 R MERGE (I) : 0.09000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 11.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.96 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.04 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 52.20 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.57 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 15% PEG4000, 10MM SODIUM CITRATE AT REMARK 280 PH5.0, 100 MM MGCL2, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE REMARK 280 278K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 2 2 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -X,Y,-Z+1/2 REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 47.63750 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 47.63750 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 44.86800 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 55.68950 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 44.86800 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 55.68950 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 47.63750 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 44.86800 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 55.68950 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 47.63750 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 44.86800 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 55.68950 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 6710 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 17930 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -28.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLU A 183 REMARK 465 HIS B -28 REMARK 465 GLY B -1 REMARK 465 SER B 0 REMARK 465 GLY B 1 REMARK 465 GLY B 2 REMARK 465 GLY B 3 REMARK 465 SER B 4 REMARK 465 ARG B 105 REMARK 465 THR B 106 REMARK 465 GLU B 107 REMARK 465 ALA B 108 REMARK 465 LEU B 109 REMARK 465 ASN B 110 REMARK 465 HIS B 111 REMARK 465 HIS B 112 REMARK 465 ALA B 190 REMARK 465 GLN B 191 REMARK 465 GLY B 192 REMARK 465 GLY B 193 REMARK 465 LEU B 194 REMARK 465 VAL B 195 REMARK 465 PRO B 196 REMARK 465 ARG B 197 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 41 CD CE NZ REMARK 470 LYS A 69 CD CE NZ REMARK 470 GLU B 5 CG CD OE1 OE2 REMARK 470 ASN B 113 CG OD1 ND2 REMARK 470 ARG B 133 NE CZ NH1 NH2 REMARK 470 ARG B 189 CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OG SER B -10 O HOH B 301 2.00 REMARK 500 OE1 GLU B 176 O HOH B 302 2.08 REMARK 500 O HOH B 323 O HOH B 423 2.12 REMARK 500 OD2 ASP A 112 O HOH A 201 2.15 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 CYS B 173 CA - CB - SG ANGL. DEV. = 9.3 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 TYR A 10 62.75 -112.04 REMARK 500 ALA B -14 -91.91 -96.16 REMARK 500 ASN B 20 71.63 50.68 REMARK 500 ASN B 34 -103.91 56.65 REMARK 500 THR B 89 -88.42 -124.00 REMARK 500 ASN B 134 65.84 31.85 REMARK 500 THR B 139 -79.13 -124.15 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 GLY B -15 ALA B -14 -145.42 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 382 DISTANCE = 7.31 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO B 201 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 6BLQ RELATED DB: PDB REMARK 999 REMARK 999 SEQUENCE REMARK 999 INSULIN MIMOTOPE DBREF 6BLR A 1 183 UNP P04228 HA2D_MOUSE 26 208 DBREF 6BLR B 4 191 UNP Q31135 Q31135_MOUSE 30 217 SEQADV 6BLR CYS A 64 UNP P04228 ASN 89 ENGINEERED MUTATION SEQADV 6BLR HIS B -28 UNP Q31135 SEE REMARK 999 SEQADV 6BLR LEU B -27 UNP Q31135 SEE REMARK 999 SEQADV 6BLR VAL B -26 UNP Q31135 SEE REMARK 999 SEQADV 6BLR GLU B -25 UNP Q31135 SEE REMARK 999 SEQADV 6BLR ARG B -24 UNP Q31135 SEE REMARK 999 SEQADV 6BLR LEU B -23 UNP Q31135 SEE REMARK 999 SEQADV 6BLR TYR B -22 UNP Q31135 SEE REMARK 999 SEQADV 6BLR LEU B -21 UNP Q31135 SEE REMARK 999 SEQADV 6BLR VAL B -20 UNP Q31135 SEE REMARK 999 SEQADV 6BLR CYS B -19 UNP Q31135 SEE REMARK 999 SEQADV 6BLR GLY B -18 UNP Q31135 SEE REMARK 999 SEQADV 6BLR GLU B -17 UNP Q31135 SEE REMARK 999 SEQADV 6BLR GLU B -16 UNP Q31135 SEE REMARK 999 SEQADV 6BLR GLY B -15 UNP Q31135 LINKER SEQADV 6BLR ALA B -14 UNP Q31135 LINKER SEQADV 6BLR GLY B -13 UNP Q31135 LINKER SEQADV 6BLR GLY B -12 UNP Q31135 LINKER SEQADV 6BLR GLY B -11 UNP Q31135 LINKER SEQADV 6BLR SER B -10 UNP Q31135 LINKER SEQADV 6BLR LEU B -9 UNP Q31135 LINKER SEQADV 6BLR VAL B -8 UNP Q31135 LINKER SEQADV 6BLR GLY B -7 UNP Q31135 LINKER SEQADV 6BLR GLY B -1 UNP Q31135 LINKER SEQADV 6BLR SER B 0 UNP Q31135 LINKER SEQADV 6BLR GLY B 1 UNP Q31135 LINKER SEQADV 6BLR GLY B 2 UNP Q31135 LINKER SEQADV 6BLR GLY B 3 UNP Q31135 LINKER SEQADV 6BLR GLY B 192 UNP Q31135 EXPRESSION TAG SEQADV 6BLR GLY B 193 UNP Q31135 EXPRESSION TAG SEQADV 6BLR LEU B 194 UNP Q31135 EXPRESSION TAG SEQADV 6BLR VAL B 195 UNP Q31135 EXPRESSION TAG SEQADV 6BLR PRO B 196 UNP Q31135 EXPRESSION TAG SEQADV 6BLR ARG B 197 UNP Q31135 EXPRESSION TAG SEQRES 1 A 183 ASP ILE GLU ALA ASP HIS VAL GLY PHE TYR GLY THR THR SEQRES 2 A 183 VAL TYR GLN SER PRO GLY ASP ILE GLY GLN TYR THR HIS SEQRES 3 A 183 GLU PHE ASP GLY ASP GLU LEU PHE TYR VAL ASP LEU ASP SEQRES 4 A 183 LYS LYS LYS THR VAL TRP ARG LEU PRO GLU PHE GLY GLN SEQRES 5 A 183 LEU ILE LEU PHE GLU PRO GLN GLY GLY LEU GLN CYS ILE SEQRES 6 A 183 ALA ALA GLU LYS HIS ASN LEU GLY ILE LEU THR LYS ARG SEQRES 7 A 183 SER ASN PHE THR PRO ALA THR ASN GLU ALA PRO GLN ALA SEQRES 8 A 183 THR VAL PHE PRO LYS SER PRO VAL LEU LEU GLY GLN PRO SEQRES 9 A 183 ASN THR LEU ILE CYS PHE VAL ASP ASN ILE PHE PRO PRO SEQRES 10 A 183 VAL ILE ASN ILE THR TRP LEU ARG ASN SER LYS SER VAL SEQRES 11 A 183 THR ASP GLY VAL TYR GLU THR SER PHE LEU VAL ASN ARG SEQRES 12 A 183 ASP HIS SER PHE HIS LYS LEU SER TYR LEU THR PHE ILE SEQRES 13 A 183 PRO SER ASP ASP ASP ILE TYR ASP CYS LYS VAL GLU HIS SEQRES 14 A 183 TRP GLY LEU GLU GLU PRO VAL LEU LYS HIS TRP GLU PRO SEQRES 15 A 183 GLU SEQRES 1 B 221 HIS LEU VAL GLU ARG LEU TYR LEU VAL CYS GLY GLU GLU SEQRES 2 B 221 GLY ALA GLY GLY GLY SER LEU VAL GLY GLY SER GLY GLY SEQRES 3 B 221 GLY SER GLU ARG HIS PHE VAL HIS GLN PHE LYS GLY GLU SEQRES 4 B 221 CYS TYR PHE THR ASN GLY THR GLN ARG ILE ARG LEU VAL SEQRES 5 B 221 THR ARG TYR ILE TYR ASN ARG GLU GLU TYR LEU ARG PHE SEQRES 6 B 221 ASP SER ASP VAL GLY GLU TYR ARG ALA VAL THR GLU LEU SEQRES 7 B 221 GLY ARG HIS SER ALA GLU TYR TYR ASN LYS GLN TYR LEU SEQRES 8 B 221 GLU ARG THR ARG ALA GLU LEU ASP THR ALA CYS ARG HIS SEQRES 9 B 221 ASN TYR GLU GLU THR GLU VAL PRO THR SER LEU ARG ARG SEQRES 10 B 221 LEU GLU GLN PRO ASN VAL ALA ILE SER LEU SER ARG THR SEQRES 11 B 221 GLU ALA LEU ASN HIS HIS ASN THR LEU VAL CYS SER VAL SEQRES 12 B 221 THR ASP PHE TYR PRO ALA LYS ILE LYS VAL ARG TRP PHE SEQRES 13 B 221 ARG ASN GLY GLN GLU GLU THR VAL GLY VAL SER SER THR SEQRES 14 B 221 GLN LEU ILE ARG ASN GLY ASP TRP THR PHE GLN VAL LEU SEQRES 15 B 221 VAL MET LEU GLU MET THR PRO HIS GLN GLY GLU VAL TYR SEQRES 16 B 221 THR CYS HIS VAL GLU HIS PRO SER LEU LYS SER PRO ILE SEQRES 17 B 221 THR VAL GLU TRP ARG ALA GLN GLY GLY LEU VAL PRO ARG HET EDO B 201 4 HETNAM EDO 1,2-ETHANEDIOL HETSYN EDO ETHYLENE GLYCOL FORMUL 3 EDO C2 H6 O2 FORMUL 4 HOH *340(H2 O) HELIX 1 AA1 LEU A 47 GLN A 52 5 6 HELIX 2 AA2 PRO A 58 SER A 79 1 22 HELIX 3 AA3 THR B 52 LEU B 54 5 3 HELIX 4 AA4 GLY B 55 ALA B 77 1 23 HELIX 5 AA5 ALA B 77 THR B 85 1 9 SHEET 1 AA1 8 LYS A 42 TRP A 45 0 SHEET 2 AA1 8 ASP A 31 ASP A 37 -1 N TYR A 35 O VAL A 44 SHEET 3 AA1 8 ILE A 21 PHE A 28 -1 N HIS A 26 O LEU A 33 SHEET 4 AA1 8 HIS A 6 SER A 17 -1 N PHE A 9 O GLU A 27 SHEET 5 AA1 8 PHE B 8 THR B 19 -1 O GLY B 14 N GLY A 11 SHEET 6 AA1 8 ARG B 24 TYR B 33 -1 O VAL B 28 N GLU B 15 SHEET 7 AA1 8 GLU B 36 ASP B 42 -1 O GLU B 36 N TYR B 33 SHEET 8 AA1 8 TYR B 48 ALA B 50 -1 O ARG B 49 N ARG B 40 SHEET 1 AA2 2 ILE A 54 LEU A 55 0 SHEET 2 AA2 2 VAL B -26 GLU B -25 1 O VAL B -26 N LEU A 55 SHEET 1 AA3 4 GLN A 90 PRO A 95 0 SHEET 2 AA3 4 ASN A 105 ILE A 114 -1 O PHE A 110 N THR A 92 SHEET 3 AA3 4 PHE A 147 PHE A 155 -1 O PHE A 147 N ILE A 114 SHEET 4 AA3 4 TYR A 135 GLU A 136 -1 N TYR A 135 O TYR A 152 SHEET 1 AA4 4 GLN A 90 PRO A 95 0 SHEET 2 AA4 4 ASN A 105 ILE A 114 -1 O PHE A 110 N THR A 92 SHEET 3 AA4 4 PHE A 147 PHE A 155 -1 O PHE A 147 N ILE A 114 SHEET 4 AA4 4 LEU A 140 VAL A 141 -1 N LEU A 140 O HIS A 148 SHEET 1 AA5 4 LYS A 128 VAL A 130 0 SHEET 2 AA5 4 ASN A 120 ARG A 125 -1 N ARG A 125 O LYS A 128 SHEET 3 AA5 4 TYR A 163 GLU A 168 -1 O LYS A 166 N THR A 122 SHEET 4 AA5 4 VAL A 176 HIS A 179 -1 O LYS A 178 N CYS A 165 SHEET 1 AA6 4 ASN B 98 SER B 102 0 SHEET 2 AA6 4 THR B 114 PHE B 122 -1 O VAL B 116 N SER B 102 SHEET 3 AA6 4 PHE B 155 GLU B 162 -1 O VAL B 159 N CYS B 117 SHEET 4 AA6 4 VAL B 142 SER B 144 -1 N SER B 143 O MET B 160 SHEET 1 AA7 4 ASN B 98 SER B 102 0 SHEET 2 AA7 4 THR B 114 PHE B 122 -1 O VAL B 116 N SER B 102 SHEET 3 AA7 4 PHE B 155 GLU B 162 -1 O VAL B 159 N CYS B 117 SHEET 4 AA7 4 ILE B 148 ARG B 149 -1 N ILE B 148 O GLN B 156 SHEET 1 AA8 4 GLN B 136 GLU B 137 0 SHEET 2 AA8 4 LYS B 128 ARG B 133 -1 N ARG B 133 O GLN B 136 SHEET 3 AA8 4 TYR B 171 GLU B 176 -1 O HIS B 174 N ARG B 130 SHEET 4 AA8 4 ILE B 184 TRP B 188 -1 O TRP B 188 N TYR B 171 SSBOND 1 CYS A 64 CYS B -19 1555 1555 2.04 SSBOND 2 CYS A 109 CYS A 165 1555 1555 2.01 SSBOND 3 CYS B 16 CYS B 78 1555 1555 2.05 SSBOND 4 CYS B 117 CYS B 173 1555 1555 2.07 CISPEP 1 SER A 17 PRO A 18 0 -5.81 CISPEP 2 PHE A 115 PRO A 116 0 -5.40 CISPEP 3 ALA B -14 GLY B -13 0 -4.41 CISPEP 4 TYR B 123 PRO B 124 0 0.78 SITE 1 AC1 8 GLY A 73 ILE A 74 LYS A 77 HOH A 231 SITE 2 AC1 8 SER B -10 GLY B -11 GLY B -12 HOH B 313 CRYST1 89.736 111.379 95.275 90.00 90.00 90.00 C 2 2 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011144 0.000000 0.000000 0.00000 SCALE2 0.000000 0.008978 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010496 0.00000